Have taken a modest stake in RWS, which has niche market in patent translations into various languages for blue chip customers. Market cap approx 120M, but has 20M cash in the bank and excellent track record on profit/cash generation. Shares have been punished recently because of a forthcoming European Directive which will affect need for some translations. IMO the drop in the price from 360p to the 3 I paid looks overdone, but we shall see. Might be worth a look for those interested in medium term investing. Always DYOR

Splendid results to 30th Sept., upstaged by large acquisition of Moravia since. Jury out on that one yet, but with other business trading strongly at the start of the new financial year and Moravia hoping to "immediately and highly" add to earnings, mine locked away in the ISA. Always dyor.

One of Questor's favourites and tipped as a buy.

Half year results show back on track after recent concern over forex, albeit RWS now becoming a large animal to manage. Lot to digest with Moravia acquisition, but senior management changes across the group suggest Andrew Brode still on the ball. 15% increase in interim divi higher than expected and a sign of confidence. Debt looks like it can be paid down fairly quickly. Always dyor.